fbpx
Myonexus

Company Profile

Myonexus Therapeutics is a clinical stage gene therapy company developing first-ever treatments for Limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a leader in muscular dystrophy gene therapy discovery and translational research.

Company Info

HQ

Columbus, Ohio

Founded

2016

Founders and CEO

  • Dr. Michael Triplett, Founder and CEO

Sector

Biosciences

Social Media